| Dr Robert C Hunter Jr, MD | |
|
700 Katlian St Ste E, Sitka, AK 99835-7359 | |
| (907) 747-5861 | |
| (907) 747-5415 |
| Full Name | Dr Robert C Hunter Jr |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 47 Years |
| Location | 700 Katlian St Ste E, Sitka, Alaska |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093887358 | NPI | - | NPPES |
| MD1784 | Medicaid | AK |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 1784 (Alaska) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mt Edgecumbe Hospital | Sitka, AK | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Southeast Alaska Regional Health Consortium | 1456265362 | 226 |
News Archive
The National Institute of General Medical Sciences of the National Institutes of Health recently awarded Lori A. Pile, Ph.D., assistant professor of molecular cell biology in Wayne State University's College of Liberal Arts and Sciences, $1.39 million to research how the alteration of chromatin regulates cellular division and growth.
In 2009, after The New York Times reported a series of mistakes in radiation therapy delivery, a team of radiation oncologists at the Kimmel Cancer Center at Jefferson decided to investigate how thoroughly different hospitals use "chart rounds" to review the radiotherapy cancer patients receive.
An article, published in Circulation by Laurel K. Leslie, MD, MPH from the Tufts Clinical and Translational Science Institute (CTSI) and colleagues from Tufts Medical Center and Floating Hospital for Children at Tufts Medical Center, has evaluated the lifesaving benefits and costs of screening programs for the prevention of sudden cardiac death (SCD) in children and adolescents.
Amgen today announced detailed results from a new biomarker analysis of the pivotal Phase 3 "408" trial of Vectibix® (panitumumab) plus best supportive care compared to BSC alone. The analysis used massively parallel, next-generation sequencing technology to investigate whether mutations in nine genes known to be mutated in colorectal cancer, including the previously unanalyzed exon 3 mutation of the KRAS gene, are predictive of response to Vectibix in metastatic colorectal cancer.
Surprise medical bills — those unexpected and often pricey bills patients face when they get care from a doctor or hospital that isn't in their insurance network — are the health care problem du jour in Washington, with congressional lawmakers from both sides of the aisle and the White House calling for action.
› Verified 8 days ago
| Entity Name | Southeast Alaska Regional Health Consortium |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376758037 PECOS PAC ID: 1456265362 Enrollment ID: O20031114000631 |
News Archive
The National Institute of General Medical Sciences of the National Institutes of Health recently awarded Lori A. Pile, Ph.D., assistant professor of molecular cell biology in Wayne State University's College of Liberal Arts and Sciences, $1.39 million to research how the alteration of chromatin regulates cellular division and growth.
In 2009, after The New York Times reported a series of mistakes in radiation therapy delivery, a team of radiation oncologists at the Kimmel Cancer Center at Jefferson decided to investigate how thoroughly different hospitals use "chart rounds" to review the radiotherapy cancer patients receive.
An article, published in Circulation by Laurel K. Leslie, MD, MPH from the Tufts Clinical and Translational Science Institute (CTSI) and colleagues from Tufts Medical Center and Floating Hospital for Children at Tufts Medical Center, has evaluated the lifesaving benefits and costs of screening programs for the prevention of sudden cardiac death (SCD) in children and adolescents.
Amgen today announced detailed results from a new biomarker analysis of the pivotal Phase 3 "408" trial of Vectibix® (panitumumab) plus best supportive care compared to BSC alone. The analysis used massively parallel, next-generation sequencing technology to investigate whether mutations in nine genes known to be mutated in colorectal cancer, including the previously unanalyzed exon 3 mutation of the KRAS gene, are predictive of response to Vectibix in metastatic colorectal cancer.
Surprise medical bills — those unexpected and often pricey bills patients face when they get care from a doctor or hospital that isn't in their insurance network — are the health care problem du jour in Washington, with congressional lawmakers from both sides of the aisle and the White House calling for action.
› Verified 8 days ago
| Entity Name | Southeast Alaska Regional Health Consortium |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1720062524 PECOS PAC ID: 1456265362 Enrollment ID: O20150921000532 |
News Archive
The National Institute of General Medical Sciences of the National Institutes of Health recently awarded Lori A. Pile, Ph.D., assistant professor of molecular cell biology in Wayne State University's College of Liberal Arts and Sciences, $1.39 million to research how the alteration of chromatin regulates cellular division and growth.
In 2009, after The New York Times reported a series of mistakes in radiation therapy delivery, a team of radiation oncologists at the Kimmel Cancer Center at Jefferson decided to investigate how thoroughly different hospitals use "chart rounds" to review the radiotherapy cancer patients receive.
An article, published in Circulation by Laurel K. Leslie, MD, MPH from the Tufts Clinical and Translational Science Institute (CTSI) and colleagues from Tufts Medical Center and Floating Hospital for Children at Tufts Medical Center, has evaluated the lifesaving benefits and costs of screening programs for the prevention of sudden cardiac death (SCD) in children and adolescents.
Amgen today announced detailed results from a new biomarker analysis of the pivotal Phase 3 "408" trial of Vectibix® (panitumumab) plus best supportive care compared to BSC alone. The analysis used massively parallel, next-generation sequencing technology to investigate whether mutations in nine genes known to be mutated in colorectal cancer, including the previously unanalyzed exon 3 mutation of the KRAS gene, are predictive of response to Vectibix in metastatic colorectal cancer.
Surprise medical bills — those unexpected and often pricey bills patients face when they get care from a doctor or hospital that isn't in their insurance network — are the health care problem du jour in Washington, with congressional lawmakers from both sides of the aisle and the White House calling for action.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Robert C Hunter Jr, MD 700 Katlian St Ste E, Sitka, AK 99835-7359 Ph: (907) 747-5861 | Dr Robert C Hunter Jr, MD 700 Katlian St Ste E, Sitka, AK 99835-7359 Ph: (907) 747-5861 |
News Archive
The National Institute of General Medical Sciences of the National Institutes of Health recently awarded Lori A. Pile, Ph.D., assistant professor of molecular cell biology in Wayne State University's College of Liberal Arts and Sciences, $1.39 million to research how the alteration of chromatin regulates cellular division and growth.
In 2009, after The New York Times reported a series of mistakes in radiation therapy delivery, a team of radiation oncologists at the Kimmel Cancer Center at Jefferson decided to investigate how thoroughly different hospitals use "chart rounds" to review the radiotherapy cancer patients receive.
An article, published in Circulation by Laurel K. Leslie, MD, MPH from the Tufts Clinical and Translational Science Institute (CTSI) and colleagues from Tufts Medical Center and Floating Hospital for Children at Tufts Medical Center, has evaluated the lifesaving benefits and costs of screening programs for the prevention of sudden cardiac death (SCD) in children and adolescents.
Amgen today announced detailed results from a new biomarker analysis of the pivotal Phase 3 "408" trial of Vectibix® (panitumumab) plus best supportive care compared to BSC alone. The analysis used massively parallel, next-generation sequencing technology to investigate whether mutations in nine genes known to be mutated in colorectal cancer, including the previously unanalyzed exon 3 mutation of the KRAS gene, are predictive of response to Vectibix in metastatic colorectal cancer.
Surprise medical bills — those unexpected and often pricey bills patients face when they get care from a doctor or hospital that isn't in their insurance network — are the health care problem du jour in Washington, with congressional lawmakers from both sides of the aisle and the White House calling for action.
› Verified 8 days ago
Courtney Alana Hayashi Vickery, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 222 Tongass Dr, Sitka, AK 99835 Phone: 907-966-2411 | |
Dr. Charles Michael Roesel, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 209 Moller Ave, Sitka, AK 99835 Phone: 907-747-1722 Fax: 907-747-1755 | |
Dr. John A Baciocco, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 222 Tongass Dr, Sitka, AK 99835 Phone: 907-966-2411 Fax: 907-966-8606 | |
Grace T Hwang, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 700 Katlian St Ste E, Sitka, AK 99835 Phone: 907-747-5136 Fax: 907-747-5415 | |
Dr. Myron Fribush, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 209 Moller Ave, Mountainside Family Healthcare, Sitka, AK 99835 Phone: 907-747-1722 Fax: 907-747-1755 | |
Debra Brushafer, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 209 Moller Ave, Sitka, AK 99835 Phone: 907-747-3241 |